Novo Nordisk is discontinuing one of its discounted insulin brands, Levemir, because of manufacturing issues, decreasing patient coverage, and the availability of alternative treatments.

Three U.S. Senators say they are "alarmed" Novo Nordisk discontinued U.S. sales of a popular insulin brand and are demanding ... to discontinue Levemir, a long-acting insulin, "failed to take ...